Candel Therapeutics, Inc. (CADL) › Shareholders' EquityCandel Therapeutics, Inc. (CADL) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2019: -$8.04M2020: -$23.56M2021: $64.14M2022: $47.71M2023: $12.74M2024: $66.33M2025: $51.92M$51.92M2019Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$51.92M-21.7%2024$66.33M+420.4%2023$12.74M-73.3%2022$47.71M-25.6%2021$64.14M+372.2%2020-$23.56M-193.1%2019-$8.04M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share